The landscape of dementia diagnosis has progressed radically with the arrival of innovative biomarkers, such as amyloid PET scans, tau imaging, and blood-based assessments that will detect Alzheimer's pathology several years prior to symptoms arise. Although these technological advances characterize exceptional development in comprehension neurodegenerative illnesses, they may have not https://henryx874whs5.azzablog.com/profile